Danciu Mihai, Simion LaurenŢiu, Poroch Vladimir, Pădureanu Sergiu Serghei, Constantinescu Răzvan Nicolae, Arhire Lidia Iuliana, Mihalache Laura
Department of Surgery, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania;
Rom J Morphol Embryol. 2016;57(4):1303-1311.
Helicobacter pylori (H. pylori) is the etiological factor for gastritis in more than half of the worldwide population. H. pylori infection increases the risk for gastric pathology, but could also have consequences on cardio-metabolic status. Obesity has as epidemic growth, and the only efficient long-term treatment for morbidly obese patients is currently surgery. Although of vital importance, the preoperative assessment is not standardized, including the aspects related to H. pylori infection. The aim of this prospective study was to evaluate the prevalence of H. pylori (Hp) infection in a group of patients referred to bariatric surgery and the agreement of two commonly used methods for its diagnosis. We included 70 asymptomatic obese patients consecutively for 14 months, who were evaluated by serology (anti-Hp IgG antibodies) and by histology (gastroscopy with gastric mucosa biopsy). If diagnosed, H. pylori infection was standard treated and afterwards, all patients underwent laparoscopic sleeve gastrectomy; the resected stomach was morphologically evaluated. 58.6% of patients were H. pylori positive on serology and 51.4% were H. pylori positive on histology, agreement coefficient factor kappa between the two methods being 0.686, p<0.001. The serological diagnosis had a sensibility of 90.3% and a specificity of 77.8%. The prevalence of H. pylori infection in the resected stomach was 11.4%, and was associated with more severe degrees of chronic gastritis. In conclusion, as gastroscopy should anyhow be performed in all patients referred to surgery, our data favor the histological evaluation in all patients and the eradication treatment according to its results.
幽门螺杆菌(H. pylori)是全球半数以上人群胃炎的致病因素。幽门螺杆菌感染会增加胃部病变的风险,但也可能对心脏代谢状况产生影响。肥胖呈流行趋势增长,目前病态肥胖患者唯一有效的长期治疗方法是手术。尽管术前评估至关重要,但尚未标准化,包括与幽门螺杆菌感染相关的方面。这项前瞻性研究的目的是评估一组接受减肥手术患者中幽门螺杆菌(Hp)感染的患病率,以及两种常用诊断方法的一致性。我们连续14个月纳入了70例无症状肥胖患者,通过血清学(抗Hp IgG抗体)和组织学(胃镜检查及胃黏膜活检)进行评估。如果确诊幽门螺杆菌感染,则进行标准治疗,之后所有患者均接受腹腔镜袖状胃切除术;对切除的胃进行形态学评估。血清学检测显示58.6%的患者幽门螺杆菌呈阳性,组织学检测显示51.4%的患者幽门螺杆菌呈阳性,两种方法之间的一致性系数kappa为0.686,p<0.001。血清学诊断的敏感性为90.3%,特异性为77.8%。切除胃中幽门螺杆菌感染的患病率为11.4%,且与更严重程度的慢性胃炎相关。总之,由于无论如何都应对所有接受手术的患者进行胃镜检查,我们的数据支持对所有患者进行组织学评估,并根据结果进行根除治疗。